Home
Fagron

Fagron Market Share Analysis for July 2026

Trough personalized medicine, we aim to make a difference in people’s well-being.

Industry: N/A

Domainfagron.co.za

Year Founded1990

Employees1001 - 5000

Annual Revenue$500M - $1B

Fagron

Fagron (including company regionals)

fagron.co.za

See more website traffic and engagement information

Fagron Revenue up to July 2026 is 500M - 1B

revenue generated by Fagron top domains

Fagron top domains revenue over 3 years

Revenue for Fagron top domains

fagron.co.za500M - 1B

See more with Sales Intelligence

Total visits to Fagron's top domains

Understand Fagron market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

fagron.co.za15.2K

See more with Sales Intelligence

Avg. visit duration in Fagron's top domains

Analyze Fagron engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

fagron.co.za00:02:23

See more with Sales Intelligence

Avg. pageviews on Fagron's top domains

See how Fagron keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

fagron.co.za3.45

See more with Sales Intelligence

Fagron top competitors by domain

Top similar sites in July 2026, ranked by their affinity

compounding.co.zaCompany NameThe Compounding PharmacyEmployees201 - 500HQSouth Africa, JohannesburgAnnual revenue$2M - $5MTotal visits2.2KHealth > Health - Other

Top technologies used by Fagron

These are the website technologies, by industry, used by Fagron top domains

Payment & Currencies (8)

Cart Functionality

Advertising (6)

DoubleClick

Widget (5)

Twemoji

Content Management System (3)

WordPress

More Technologies

10

See all

News & Signals from Fagron

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsFagron SA acquires Guinama.Fagron, a global leader in pharmaceutical compounding, has announced the acquisition of Guinama, a Spanish company known for repackaging and distributing active pharmaceutical ingredients.